$2.38T
Total marketcap
$39.81B
Total volume
BTC 50.81%     ETH 14.77%
Dominance

CEN Biotech CENBF Stock

0.005 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
326.28K USD
LOW - HIGH [24H]
0.0050 - 0.0050 USD
VOLUME [24H]
375 USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.03 USD

CEN Biotech Price Chart

CEN Biotech CENBF Financial and Trading Overview

CEN Biotech stock price 0.0050 USD
Previous Close 0.02 USD
Open 0.02 USD
Bid N/A x N/A
Ask N/A x N/A
Day's Range 0.02 - 0.02 USD
52 Week Range 0.01 - 0.32 USD
Volume 150 USD
Avg. Volume 8.82K USD
Market Cap 1.39M USD
Beta (5Y Monthly) 0.881144
PE Ratio (TTM) N/A
EPS (TTM) -0.03 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

CENBF Valuation Measures

Enterprise Value 6.84M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 1.3455094
Price/Book (mrq) N/A
Enterprise Value/Revenue 6.618
Enterprise Value/EBITDA -7.682

Trading Information

CEN Biotech Stock Price History

Beta (5Y Monthly) 0.881144
52-Week Change -69.65%
S&P500 52-Week Change 20.43%
52 Week High 0.32 USD
52 Week Low 0.01 USD
50-Day Moving Average 0.04 USD
200-Day Moving Average 0.04 USD

CENBF Share Statistics

Avg. Volume (3 month) 8.82K USD
Avg. Daily Volume (10-Days) 1.05K USD
Shares Outstanding 65.26M
Float 25.87M
Short Ratio N/A
% Held by Insiders 53.76%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2021
Most Recent Quarter (mrq) September 30, 2022
Next Fiscal Year End December 31, 2022

Profitability

Profit Margin -299.68%
Operating Margin (ttm) -127.54%
Gross Margin 100.00%
EBITDA Margin -86.13%

Management Effectiveness

Return on Assets (ttm) -10.095%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 1.03M USD
Revenue Per Share (ttm) 0.02 USD
Quarterly Revenue Growth (yoy) -50.10%
Gross Profit (ttm) 626.87K USD
EBITDA -889849 USD
Net Income Avi to Common (ttm) -3095861 USD
Diluted EPS (ttm) -0.05
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 148.15K USD
Total Cash Per Share (mrq) 0.002 USD
Total Debt (mrq) 5.62M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.031
Book Value Per Share (mrq) -0.033

Cash Flow Statement

Operating Cash Flow (ttm) -590725 USD
Levered Free Cash Flow (ttm) -56938 USD

Profile of CEN Biotech

Country United States
State ON
City Windsor
Address 3295 Quality Way
ZIP N8T 3R9
Phone N/A
Website https://www.cenbiotechinc.com
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees 4

CEN Biotech, Inc. focuses on the manufacture, production, and development of light emitting diode lighting technology and hemp-based products. It intends to cultivate hemp for usage in industrial, medical, and food products; and to provide digital marketing and web design related services. The company was incorporated in 2013 and is based in Windsor, Canada.

Q&A For CEN Biotech Stock

What is a current CENBF stock price?

CEN Biotech CENBF stock price today per share is 0.0050 USD.

How to purchase CEN Biotech stock?

You can buy CENBF shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for CEN Biotech?

The stock symbol or ticker of CEN Biotech is CENBF.

Which industry does the CEN Biotech company belong to?

The CEN Biotech industry is Drug Manufacturers-Specialty & Generic.

How many shares does CEN Biotech have in circulation?

The max supply of CEN Biotech shares is 65.26M.

What is CEN Biotech Price to Earnings Ratio (PE Ratio)?

CEN Biotech PE Ratio is now.

What was CEN Biotech earnings per share over the trailing 12 months (TTM)?

CEN Biotech EPS is -0.03 USD over the trailing 12 months.

Which sector does the CEN Biotech company belong to?

The CEN Biotech sector is Healthcare.